GIA
ABEO icon

Gem Investment Advisors’s Abeona Therapeutics ABEO Stock Holding History

Gem Investment Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$612K Buy
+99,084
New +$544K 0.38% 26

Other funds holding ABEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gem Investment Advisors's ABEO Position: Q2 2026 in Review

Gem Investment Advisors opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 99,084 shares worth $612K. The stake represents 0.38% of the portfolio and ranks #26 among its holdings.

51 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Gem Investment Advisors held 99,084 shares of Abeona Therapeutics worth $612K as of Q2 2026.
  • Abeona Therapeutics was a new Gem Investment Advisors position in Q2 2026.
  • Abeona Therapeutics made up 0.38% of Gem Investment Advisors's portfolio in Q2 2026, its #26 holding.
  • 51 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Gem Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.